3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
27
Myelodysplastic Syndromes
6
Leukemia, Biphenotypic, Acute
4
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid
2
Leukemia
2
Blast Crisis
2
Sarcoma, Myeloid
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
Carcinoma, Hepatocellular
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Tretinoin
3
Arsenic Trioxide
3
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Magnetic Resonance Spectroscopy
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Gadolinium
1
Fluorodeoxyglucose F18
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
Idarubicin
×
90 days
×
Clear all
NCT02688140
2026-05-29
TUD-APOLLO-064
Technische Universität Dresden
Phase 3
Completed
133 enrolled